DECHENG CAPITAL
Decheng Capital is a leading investment firm that provides capital and strategic support to early stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence. We are a group of dedicated professionals with complementary expertise who have outstanding track records of building highly successful companies globally. Founded in 2012, Decheng continues to capitalize on a historic opportunity in the rapid growth of healthcare industry as well as breakthroughs in life science research. With over $2 billion in capital under management and support from some of the most prestigious LPs in the world, Decheng is poised to deliver superior returns for our investors and create value for our entrepreneur partners.
DECHENG CAPITAL
Social Links:
Industry:
Financial Services Health Care Venture Capital
Founded:
2012-01-01
Status:
Active
Contact:
(650) 233-0688
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Nginx
Similar Organizations
Echo Health Ventures
Echo Health Ventures is a venture capital firm that focuses on investing in health care companies.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-02 | Upstream Bio | Decheng Capital investment in Series A - Upstream Bio | 200 M USD |
| 2022-06-02 | Watchmaker Genomics | Decheng Capital investment in Series A - Watchmaker Genomics | 40 M USD |
| 2022-05-17 | Mirvie | Decheng Capital investment in Series B - Mirvie | 45 M USD |
| 2022-05-12 | USCI medical laboratory | Decheng Capital investment in Private Equity Round - USCI medical laboratory | N/A |
| 2022-02-17 | Nalu Medical | Decheng Capital investment in Venture Round - Nalu Medical | 104 M USD |
| 2022-01-20 | ImmPACT Bio | Decheng Capital investment in Series B - ImmPACT Bio | 111 M USD |
| 2021-12-27 | Kind Pharmaceutical | Decheng Capital investment in Series B - Kind Pharmaceutical | 50 M USD |
| 2021-11-16 | ACELYRIN | Decheng Capital investment in Series B - ACELYRIN | 250 M USD |
| 2021-09-15 | Alpine Immune Sciences | Decheng Capital investment in Post-IPO Equity - Alpine Immune Sciences | 91 M USD |
| 2021-09-09 | Mammoth Biosciences | Decheng Capital investment in Series D - Mammoth Biosciences | 150 M USD |